Table 1.
Patient Demographics.
| Variable (Mean ± SD) | Polycystic Ovary Syndrome (N = 34) | Endometrial Cancer (N = 34) | Control (N = 34) |
|---|---|---|---|
| Age (Years) | 31.8 ± 5.97 | 63.44 ± 10.07 * | 43.68 ± 13.12 |
| Menstrual phase | Proliferative = 34 | Premenopause = 4 Perimenopause = 13 Postmenopause = 17 |
Premenopause = 20 Perimenopause = 14 |
| BMI (kg/m2) | 29.28 ± 2.91 | 32.22± 5.70 * | 28.58 ± 2.62 |
| WHR | 0.88 ± 0.03 | 0.91 ± 0.04 * | 0.85 ± 0.02 |
| Systolic BP | 133.4 ± 7.09 | 146.7 ± 10.7 * | 134.5 ± 8.4 |
| Diastolic BP | 82.2 ± 7.95 | 87.5 ± 6.9 | 80.56 ± 7.0 |
| Fasting Glucose (mmol/L) | 5.16 ± 0.78 | 6.3 ± 1.5 * | 4.9 ± 0.5 |
| HOMA-IR | 0.25 ± 0.39 | 0.28 ± 0.33 | 0.17 ± 0.10 |
| LDL (mmol/L) | 2.74 ± 0.77 | 2.57 ± 1.07 | 2.75 ± 0.80 |
| HDL (mmol/L) | 1.44 ± 0.33 | 1.63 ± 0.34 | 1.47 ± 0.33 |
| TG (mmol/L) | 1.43 ± 0.51 | 1.51 ± 0.54 | 1.38 ± 0.60 |
| Total Cholesterol | 4.73 ± 0.91 | 4.59 ± 1.39 | 4.94 ± 0.98 |
*—p-value < 0.001; HOMA-IR—homeostatic model assessment of insulin resistance; BP—blood pressure; SD—standard deviation; BMI—body mass index; WHR—waist–hip ratio; TG—triglycerides; LDL—low density lipoproteins; HDL—high density lipoproteins.